Skip to main content

Table 3 Treatment related adverse events

From: Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer

Adverse event

Number of patients experiencing adverse event

Grade 1

Grade 2

Grade 3

Grade 4

Total (%)

Fatigue

5

1

0

0

6 (50)

Hypoalbuminemia

2

4

0

0

6 (50)

Hyponatremia

6

0

0

0

6 (50)

Anemia

3

1

1

0

5 (42)

Elevated transaminases

3

2

0

0

5 (42)

Fever

4

1

0

0

5 (42)

Elevated alkaline phosphatase

2

0

2

0

4 (33)

Lymphopenia

3

1

0

0

4 (33)

Injection site reaction

3

1

0

0

4 (33)

Hypocalcemia

2

1

0

0

3 (25)

Myalgia

3

0

0

0

3 (25)

Neutropenia

3

0

0

0

3 (25)

Chills

2

0

0

0

2 (17)

Flu-like symptoms

2

0

0

0

2 (17)

Leukopenia

2

0

0

0

2 (17)

Arthritis

1

0

0

0

1 (8)

Decreased BUN

1

0

0

0

1 (8)

Hypertension

0

0

1

0

1 (8)

Hot flashes

1

0

0

0

1 (8)

Hyperbilirubinemia

1

0

0

0

1 (8)

Hypercalcemia

1

0

0

0

1 (8)

Night sweats

1

0

0

0

1 (8)

Pain

1

0

0

0

1 (8)

Pain in extremity

1

0

0

0

1 (8)